Orforglipron vs. Rybelsus: Comparing Oral GLP-1 Options for Weight Loss
November 18, 2025
Important Note: Orforglipron is not yet FDA-approved. Eli Lilly plans to submit for regulatory review in late 2025, with potential approval expected in 2026. Rybelsus (oral [...]